text:
Authors at the London Book Fair: how things change!
by Catriona Troth
This year was my fourth year attending the London Book Fair, which gave me a chance to reflect on how things have changed for authors since that first, tentative visit.
My first impression, back in 2011, was of the vast stalls of the big publishing houses, crowded with people holding earnest conversations in twos and threes. But if you weren't part of this arcane world, then they were essentially advertising space for the publishers' most highly promoted books. And as for those agents you might long to corner and impress with that carefully honed 'elevator' pitch, they were secreted away in the International Rights Centre, where admission was by appointment only.
However, if you made it past those, there was still plenty to enjoy. Dotted around the Fair were theatres and speaking areas, each of which has their own programme of seminars and interviews. The Children's Zone, the Digital Zone, the Translation Centre, The English Pen Literary Café … the programme was so crowded that it is impossible to see everything you might be interested in.
Blink and you might miss it, but even back then, there was an author lounge. As I told Gareth Howard of Authoright recently, I recall sitting literally at his feet to hear him explain the difference between marketing and distribution, because his audience far exceeded the handful of cuboid pouffes furnishing the Lounge.
My second visit, in 2012, saw the beginning of an author revolution – the London launch of ALLi – the Alliance of Independent Authors. In a room overlooking those very publishing stands I'd stood in awe of the year before, Orna Ross, proclaimed:
"Hello. We're here. We're at the London Book Fair and we're here to stay!"
Orna Ross Launching ALLI, LBF12
And how very right she proved to be. By the following year, those upstart authors had made it down on to the floor of the fair itself, with a considerably expanded Author Lounge, sponsored by Authoright and an exciting schedule of seminars and workshops. What's more, in its first year, ALLi had created a virtual network of authors, all of whom were eager to meet in person and exchange ideas. There was a tremendous buzz of excitement and a sense that here – rather than anywhere else in the Fair – was where the real innovation was happening.
Unfortunately, despite the expansion, space became a major issue. On Monday, the audience for the talks was spilling out into the aisles outside, with people craning to hear and waiting in line in the hopes of getting a better spot for the next session as some people moved on. By Tuesday, the organisers had got twitchy about this. Those acting as gatekeepers, with their little clickers scanning our badges, were limiting the numbers coming into the lounge, and the security folk were moving people on if they even stopped outside to grab a quick photo. It all left many of us with the sense that, as authors, we were expected to play quietly while the grownups conducted business.
So what of 2014?
Arriving through the main entrance, you would be forgiven for thinking that very little had changed in the past three years. Earls Court One was still dominated by the massive stands of the big publishing houses. Literary Agents were still tucked away in their eyrie above the main floor. But head for the back of Earls Court 2, and you'd find a new confidence among the author community.
The Author Lounge – now redubbed Author HQ – was no bigger than the year before, but the layout was more 'open plan', allowing a greater numbers to access to the seminars. It was also placed in a corner of Earls Court 2 with a wide aisle in front of it, so that people overspilling it were no longer a health and safety issue.
Seminar at Author HQ, LBF14
There was, as always, a great programme of seminars for authors – from 'Breaking Through: what Independent Authors know about Reaching Readers' to 'Negotiating Author Contracts', 'How to Get the Best From Your Publisher,' and 'Top Ten Things to Know about getting your book made into a Film/TV show' (to name but a few). You can read about a selection of them here.
It was wonderful, this year, to be able to share the Fair with my Triskele colleagues, as well as reconnecting with friends from the Alliance of Independent Authors (now sporting the shiny new badges by which we could identify one another). The huge sense of energy and innovation that I'd felt the year before culminated, this year, in the ALLi/ACX party, where amidst the noisy chaos of a crowded pub, we heard readings from authors such as Dan Holloway, Polly Courtney, JJ Marsh, Jessica Bell and Jerome Griffin .
JJ Marsh - reading at the ALLi/ACX party
In some ways, I felt as if I 'came of age' at this LBF. Now I was one of the people having meetings over coffee (or wine) with the likes of ePubli, Silverwood Books, Nook Press, Writers and Artists Yearbook and Chorleywood. Unfortunately, all this meant that, despite being at the Fair for all three days, I scarcely had time to visit the English Pen Literary Cafe, where author interviews take place. Previously, I had heard crime writer Margie Orford talk about her first-hand experience of South African prisons, discovered the Anthony Horowitz seeds his books with hidden names, anagrams and other puzzles , heard William Boyd announce the title of his new Bond novel and heard the judges of the Independent Foreign Fiction Prize discuss the shortlist. This year, I caught a few minutes of Jim Crace talking about why he doesn't write political novels – and even fewer of the magnificent Malorie Blackman. But that was all.
For me, though, the most memorable part of the whole three days has to be the impassioned speeches from Dan Holloway and Debbie Young at the Open Up To Indies Launch on the Kobo stall on the first day.
Holloway challenged the publishing world to decide whether to ask, "How do we keep all the bad books out?" or "How do we make sure to let all the good books in?" and warned that the first alternative "denies reader whole swathes of the outstanding."
Young described Open Up to Indies as "an exercise in stepping beyond my self-published author's mindset to empathise with the parties that influence that important end-user of all authors' products: the reader. It was about viewing the bookshop from the other side of the till; seeing the literary festival from the frantic desk of the event manager; perceiving librarians as more than just the people who stamp your ticket."
So if you are wondering whether it might be worth making the trip to LBF15, in its new home at Olympia, here are a few reasons why you should:
To meet other authors, exchange tips and be inspired
To hear interviews with writers from around the globe
To take advantage of the huge array of free seminars and workshops available
To connect with the passion and dedication behind campaigns like Open Up to Indies
Catriona Troth is the author of the novels Ghost Town and Gift of the Raven. She is a member of the Triskele Books Author Collective, and of the Alliance of Independent Authors.
Labels: alliance of independent authors, Articles, live events, London Book Fair
Seminars for Authors - an overview from LBF 2014
By Gillian Hamer
As part of the Author HQ section at London Book Fair, I attended three seminars aimed at independent and self-published authors. Whilst I didn't learn too much I didn't already know, it was good to get confirmation that as a collective, Triskele are doing much of the right thing, and it was also interesting to participate in Q&A's with other authors in similar positions.
SEMINAR ONE - HOW TO MARKET YOUR BOOK
Speaker - Paul Andrews (CEO - AUK Ltd)
A round table session for authors, discussing marketing options and advice from a PR agency right at the centre of advertising for clients and publishers.
Lots of advice given about the importance of networking. How to use Twitter and Facebook author pages to their best potential. Also the importance not only of an easily accessible website, but how add-on mailing lists are crucial for building followers. A mention was also made to Google + and Pinternet to again build a 'conversation' with your readers and offer them insights into your world rather than bombard them with 'buy my book' messages that ultimately alienate followers.
Blogs were given a high priority, to be used as a connection port with your readers, to use them in competitions, giveaways and price promotions ahead of other readers. A discussion on the usefulness of blog tours with other authors seemed to conclude that they may have had their day and did not have any direct benefits to either increased followers or extra sales.
Paul Andrews discussed options his own agency used and how it was important to target the right audience. He recommended selected use of magazine advertising, targeting genres or regions who may be interested in your content. He also gave tips on how to get the best deal from magazines (an early enquiry followed by last minute booking.) Also recommended were book trailers, easy to produce with today's technology, to offer something different to readers.
A direct question about paid promotions like BookBub and newly formed sites springing up, led to a round table discussion about cost versus sales - making most such promotions unaffordable. Paul Andrews did not think that any other site was established enough yet to be charging large amounts for advertising and said to be cautious before committing to this form of paid adverts. He also explained how the key benefits of promotions on KDP Select via Amazon no longer had the added benefit of boosting a book up the paid charts when the promotion ended.
In summary – mailing lists and magazine adverts/editorials were the current best performing marketing avenue.
SEMINAR TWO - FILM / TV FOR AUTHORS
Speaker - Lisa Logan (Partner – Head of Media & Entertainment, GATELEY Solicitors)
A seminar led by leading solicitors, Gateley, about film and television rights from the perspective of authors, agents and publishers.
Ten sections were discussed:
1. What is an option?
2. When to pitch?
3. Options Fee / Purchase Price
4. Type of Rights
5. Prequels, sequels and spin-offs
6. Warranties and undertakings
7. Net profits
9. Option Exercise
10. Turnaround
The adaption of a book to TV or film is probably an author and / or publisher's biggest ambition. It was eye-opening to analyse just how many successful movie franchises, blockbusters and some of the highest rated television shows that actually started life as books. With such huge monetary amounts in the industry, it is arguably the most lucrative revenue source for writers and publishers.
The seminar discussed all aspects of the process of adapting a book into TV or film from drafting the correct type of option agreement to negotiating licences for literary rights and advertising agreements.
There was a lot of information to take in here. Simple topics such as 'What is an option?' were not actually simple at all once all the different options had been discussed and analysed. Issues of intellectual property and brand exploitation needed careful attention. Much of the legal jargon I'm afraid went a little over my head, although the seminar brought home to me the importance of having good legal protection especially for indie-authors who are mostly un-agented. Lisa Logan gave a series of stories about writers who had not retained correct legal advice and how this could leave an author not only out of pocket but without rights and vulnerable in a competitive world.
Some of the information given here was, for me, either obvious or not applicable for my own personal circumstances. However, I found the information given about when and out to pitch interesting and learnt about the importance of separating rights (film, TV, merchandise, digital etc.) There was also an in-depth discussion about option fees, and the importance of negotiating the right deal for your book, against the final purchase price paid for the given rights.
Also, for writers like myself, who intend to write a series, it was explained how the option fee and purchase price may include sequels and prequels rights, and how important it is for the author or publishers to ensure these rights are retained or made subject of separate negotiations.
In summary – never give away associated rights to your book without professional advice.
SEMINAR THREE - GENRE FICTION
Speakers – Authors, Katie Fforde (Romantic Fiction) Jo Fletcher (Science Fiction) and Manda Scott (Historical Fiction)
Lots of useful tips here from some hugely successful genre fiction writers. Interestingly, many of their answers echoed my own experiences and there was a feeling of inclusion, that all writers suffered similar trauma.
Discussing the biggest learning curve they'd experienced in their writing career, all three writers admitted that learning to accept feedback and the reactions to their first professional edit were something that stuck in their memory. From thinking that you had written the finished product to realising just how far away you were from a completed novel, took a lot of acceptance. And when asked about the easiest mistake many new writers fall into, they all agreed that rushing to finish a book and publishing too soon were the biggest pitfalls.
The writers discussed the specifics of their chosen genres. Jo Fletcher detailed how there was an added layer of difficulty for writers of fantasy and science-fiction. Not only did the story have to have a strong, well-paced narrative, driving the plot along, but it also had to settle the reader in the world the author created. It was also crucial to have strong, believable protagonists. It was interesting to hear Jo discuss the difference, as she saw it, between fantasy (a world that could never have been created) to science fiction (a world in a different place or time) and how it was the job of the author to get the reader on-board, so that that not only accepted, but believed, the world they inhabited throughout the novel.
Manda Scott tackled the topic of research. She explained that in order to believably set her novels in the chosen period, she had to absorb herself so much in the world her novel was set, that the language and settings became second nature to her. She also discussed how she handled the subjects of dialogue and language, and how it was unnecessary (and unwise) to use archaic language to enhance the read. As she explained, the language wasn't archaic to the people living at the time, so why make it archaic to the reader today? And she also mentioned the dreaded ALL CAPITAL EMAILS that were the bane of the historical fiction writer – these being feedback from readers who are experts on the chosen period and will take great joy in pointing out your mistakes. So, despite the fall back of disclaimers, she advised to always check your facts as much as possible with experts of your own prior to publication and not to leave research to chance or rely on Wikipedia.
Katie Fforde introduced the topic of writing groups, online and real life, as support for writers of similar genres. She highlighted the benefits of groups such as the RNA (Romantic Novelists Association) It was discussed how to both give and handle critiques and how to improve your technical skill. She also discussed the success of her Katie Fforde bursary (two of her protégés were at the event) and the input she gives and benefits she receives, plus the personal satisfaction gained, from supporting up and coming authors.
An interesting Q&A followed with writers getting lots of feedback on their chosen genres and topics where to access further advice and information.
More on the London Book Fair 2014 in our June issue ...
Posted by Words with JAM 1 comment:
Labels: Articles, Gillian Hamer, LBF, London Book Fair
Authors at the London Book Fair: how things chang...


We provide quality care to all patient from infant to geriatric. Our surgical team utilizes advanced technology to support our patients through the entire perioperative process. We are committed to quality and safety for our patients and their families. The department is equipped with the latest technology and a state-of-the-art Operation Theatre to provide care and treatment of highest quality to its patients.
The Department is run by a team of highly specialized consultants with expertise in Orthopedic, ENT, Urology, Neurosurgery, General surgery, Plastic surgery, Dental and Maxillofacial surgery.


text:
Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study)
Taisuke Otsuki, Heung Dong Kim, Guoming Luan, Yushi Inoue, Hiroshi Baba, Hirokazu Oguni, Seung Chyul Hong, Shigeki Kameyama, Katsuhiro Kobayashi, Shinichi Hirose, Hitoshi Yamamoto, Shin ichiro Hamano, Kenji Sugai
Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.
Brain and Development
https://doi.org/10.1016/j.braindev.2015.11.004
Developmental quotient
Epileptic encephalopathy
Prospective cohort study
Seizure outcome
10.1016/j.braindev.2015.11.004
Fingerprint Dive into the research topics of 'Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study)'. Together they form a unique fingerprint.
Far East Medicine & Life Sciences
Brain Diseases Medicine & Life Sciences
Vagus Nerve Stimulation Medicine & Life Sciences
Otsuki, T., Kim, H. D., Luan, G., Inoue, Y., Baba, H., Oguni, H., Hong, S. C., Kameyama, S., Kobayashi, K., Hirose, S., Yamamoto, H., Hamano, S. I., & Sugai, K. (2016). Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study). Brain and Development, 38(5), 449-460. https://doi.org/10.1016/j.braindev.2015.11.004
Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood : Results of an international multicenter cohort study in Far-East Asia (the FACE study). / Otsuki, Taisuke; Kim, Heung Dong; Luan, Guoming; Inoue, Yushi; Baba, Hiroshi; Oguni, Hirokazu; Hong, Seung Chyul; Kameyama, Shigeki; Kobayashi, Katsuhiro; Hirose, Shinichi; Yamamoto, Hitoshi; Hamano, Shin ichiro; Sugai, Kenji.
In: Brain and Development, Vol. 38, No. 5, 01.05.2016, p. 449-460.
Otsuki, T, Kim, HD, Luan, G, Inoue, Y, Baba, H, Oguni, H, Hong, SC, Kameyama, S, Kobayashi, K, Hirose, S, Yamamoto, H, Hamano, SI & Sugai, K 2016, 'Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study)', Brain and Development, vol. 38, no. 5, pp. 449-460. https://doi.org/10.1016/j.braindev.2015.11.004
Otsuki T, Kim HD, Luan G, Inoue Y, Baba H, Oguni H et al. Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study). Brain and Development. 2016 May 1;38(5):449-460. https://doi.org/10.1016/j.braindev.2015.11.004
Otsuki, Taisuke ; Kim, Heung Dong ; Luan, Guoming ; Inoue, Yushi ; Baba, Hiroshi ; Oguni, Hirokazu ; Hong, Seung Chyul ; Kameyama, Shigeki ; Kobayashi, Katsuhiro ; Hirose, Shinichi ; Yamamoto, Hitoshi ; Hamano, Shin ichiro ; Sugai, Kenji. / Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood : Results of an international multicenter cohort study in Far-East Asia (the FACE study). In: Brain and Development. 2016 ; Vol. 38, No. 5. pp. 449-460.
@article{4293130d536c4f0aa74c208a8402ebc6,
title = "Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood: Results of an international multicenter cohort study in Far-East Asia (the FACE study)",
abstract = "Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.",
keywords = "Developmental quotient, Epilepsy surgery, Epileptic encephalopathy, Prospective cohort study, Seizure outcome",
author = "Taisuke Otsuki and Kim, {Heung Dong} and Guoming Luan and Yushi Inoue and Hiroshi Baba and Hirokazu Oguni and Hong, {Seung Chyul} and Shigeki Kameyama and Katsuhiro Kobayashi and Shinichi Hirose and Hitoshi Yamamoto and Hamano, {Shin ichiro} and Kenji Sugai",
doi = "10.1016/j.braindev.2015.11.004",
journal = "Brain and Development",
T1 - Surgical versus medical treatment for children with epileptic encephalopathy in infancy and early childhood
T2 - Results of an international multicenter cohort study in Far-East Asia (the FACE study)
AU - Otsuki, Taisuke
AU - Kim, Heung Dong
AU - Luan, Guoming
AU - Inoue, Yushi
AU - Baba, Hiroshi
AU - Oguni, Hirokazu
AU - Hong, Seung Chyul
AU - Kameyama, Shigeki
AU - Kobayashi, Katsuhiro
AU - Hirose, Shinichi
AU - Yamamoto, Hitoshi
AU - Hamano, Shin ichiro
AU - Sugai, Kenji
N2 - Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.
AB - Objective To compare the seizure and developmental outcomes in infants and young children with epileptic encephalopathy who have undergone surgical and medical treatments. Methods An international, multicenter, observational cohort study was undertaken. A total of 317 children aged <6 years, who had frequent disabling seizures despite intensive medical treatments, were registered. Among the enrolled children, 250 were treated medically (medical group), 31 underwent resective surgery (resective group), and 36 underwent palliative surgery [callosotomy (n = 30) or vagal nerve stimulation (n = 6); palliative group] on admission. Seizure and developmental outcomes were obtained for 230 children during the 3-year follow-up period. Cox proportional hazard model was used to adjust for clinical backgrounds among treatment groups when comparing the seizure-free survival rates. Results At the 3-year follow-up, seizure-free survival was 15.7%, 32.1%, and 52.4% in the medical, palliative, and resective groups, respectively. The adjusted hazard ratios for seizure recurrence in the resective and palliative groups versus the medical group were 0.43 (95% CI, 0.21–0.87, P = 0.019) and 0.82 (95% CI, 0.46–1.46, P = 0.50), respectively; the former was statistically significant. Regarding the developmental outcome, the mean DQs in the resective group increased significantly compared to those in the medical group during the follow-up (P < 0.01). As for subgroup analysis, better seizure and development outcomes were demonstrated in the resective group compared to the medical group in children with nonsyndromic epilepsies (those to which no known epilepsy syndromes were applicable). Significance These results suggest that surgical treatments, particularly resective surgeries, are associated with better seizure and developmental outcomes compared with successive medical treatment. The present observations may facilitate the identification of infants and young children with epileptic encephalopathy who could benefit from surgery.
KW - Developmental quotient
KW - Epilepsy surgery
KW - Epileptic encephalopathy
KW - Prospective cohort study
KW - Seizure outcome
U2 - 10.1016/j.braindev.2015.11.004
DO - 10.1016/j.braindev.2015.11.004
JO - Brain and Development
JF - Brain and Development

redpajama_set_name: RedPajamaCommonCrawl


The gingerbread displays are always a treat to see at the Grand Floridian Resort, Yacht and Beach Club and the Boardwalk Resorts. Even if you aren't a fan of eating gingerbread, taking a trip to the resorts to see these one of a kind displays is highly recommended! At the Boardwalk Resort Chef Stitch has taken over the bakery and is creating chaos as usual! Take a look at the back of gazebo display for a fireplace. Santa Donald is coming down the chimney and if you look closely there is a Hidden Mickey on his backside! This isn't the only Hidden Mickey in this display so get hunting and if you get hungry fresh gingerbread isn't far away!


text:
Fury vs Joshua News Fury vs Joshua maybe twice in 2021 – Hearn
Fury vs Joshua maybe twice in 2021 – Hearn
Promoter Eddie Hearn says Tyson Fury and Anthony Joshua could face each other not once but twice in 2021.
The clamour for an all-British world heavyweight title unificiation fight is growing by the day, and Hearn – whose Matchroom Boxing promotes Joshua – says AJ would sign up now to face his bitter rival next year.
Hearn, speaking to Sky Sports, said of the fight everybody wants to see: "It would probably be a two-fight deal. Any deal between Fury and AJ, you run it twice. It is not a condition of the deal but it was in their deal with Deontay Wilder, and it is the biggest fight in boxing, so it is likely you will see that twice."
Despite speculation to the contrary, Hearn also added that Deontay Wilder will not be stepping aside from his third fight with Fury later this year, which means a unification showdown between the Brits must wait until 2021. And Joshua will instead go ahead with his mandatory title defence against 39-year-old Bulgarian Kubrat Pulev.
"Wilder is not going to be stepping aside so (Pulev) is the fight for us," Hearn confirmed.
"I had a conversation (on Thursday) saying: 'Wilder is not stepping aside, we will take care of that fight, you take care of the Pulev fight, but let's get a deal done for 2021'. We have no problem signing now to fight Fury in 2021.
"It will work out better for both of them to box off those fights then have a clear route, subject to Dillian Whyte being mandatory to Fury, to get [an undisputed title fight] done."
Hearn has repeatedly said that Joshua fighting Pulev behind closed doors would be a last resort land the respective camps are now looking for a venue.
Hearn said: "The focus remains the same – do the fight in the UK. We have also now conceded that AJ will only fight once this year. Before it was all about getting that fight in early-August to make sure we could fight in December. Because of the preparation needed and the magnitude of his shows, AJ will only box once in 2020.
"We hope between September and December live gates will return to the UK. There is also a chance they won't – if that's the case, we will take the fight elsewhere.
"We have had a number of approaches from the Middle East, China, and Croatia to stage the fight. We want to give ourselves every opportunity to stage it in the UK but we know it may not be possible.
"We want the mandatory defence boxed off, out of the way, before he moves into the undisputed fight next year."


Begonias are tropical plants that enjoy somewhat shady, humid environments with cool to moderate temperatures. They're most commonly grown as indoor plants for their showy foliage. The Angel Wing begonia has long cane-like stems and large, colorful leaves that are shaped like angels' wings. Clusters of hanging flowers bloom atop the 2-foot-tall canes. Angel Wing begonias are man-made hybrids that range in size from dwarf varieties to those that grow up to 4 feet tall.
Keep your Angel Wing begonia in bright, indirect light, but not in direct sun. Maintain cool to normal indoor air temperatures around your begonia of 50 to 75 degrees Fahrenheit.
Water your Angel Wing begonia when the potting soil begins to feel dry to the touch. Provide warm water until it begins to drain through the bottom of the pot. Keep your Angel Wing begonia's potting soil evenly moist but not wet or soggy.
Feed your Angel Wing begonia once every two weeks with a water-soluble, lime-free and high-nitrogen houseplant fertilizer at half the normal dosage rate. Don't fertilize the begonia while it's flowering.
Keep the air somewhat humid around your Angel Wing begonia by misting it two or three times per week with warm, lime-free water. You can also fill the drainage dish with pebbles and some water to increase humidity around the begonia, but ensure that the pot is sitting on the pebbles and not in the water.
Pot your Angel Wing begonia in a container that has drainage holes in the bottom and is filled with a rich, organic potting mixture containing peat moss and/or organic compost. You can also use a commercial potting mix made for African violets.
Watch out for mealybugs infesting your Angel Wing begonias. If you detect mealybugs, you can apply an appropriate insecticidal soap or horticultural oil to get rid of the infestation. Follow the directions on the label exactly.
Why Are My Geraniums Not Blooming?


text:
using System;
using System.IO;

namespace FezEngine.Mod {
    public class ModLogger {
        private static readonly string LogFilePath = "JAFM Log.txt";//Creates the .txt wherever the game is running (next to FEZ.exe)
        private const string TimeFormat = "HH:mm:ss.fff";

        public static void Log(string component, string message) {
            string line = "(" + DateTime.Now.ToString("HH:mm:ss.fff") + ") [" + component + "] " + message;
            Console.WriteLine(line);
            using (FileStream fileStream = File.Open(LogFilePath, FileMode.Append)) {
                using (StreamWriter streamWriter = new StreamWriter(fileStream)) {
                    streamWriter.WriteLine(line);
                }
            }
        }

        public static void Clear() {
            if (File.Exists(LogFilePath)) {
                File.Delete(LogFilePath);
            }
        }

    }
}

redpajama_set_name: RedPajamaGithub


Aromatherapy uses concentrated scents such as essential oils and natural herbs to promote physical and psychological well-being. Aromatherapy can include the inhalation of certain scents, to promote relaxation or stimulation of certain mental functions. It can also include applying oils or extracts onto the skin to be absorbed by the body. Some essential oils, when used in this way, can aid in health, hygiene and physical appearance.
Essential oils, herbs and other scents used in aromatherapy have varying levels of potency and concentration, and their application should be supervised by a trained Aromatherapy professional.


text:
Plugin.define "Google-Search-Appliance" do
author "Brendan Coles <bcoles@gmail.com>" # 2011-09-16
version "0.1"
description "The Google Search Appliance (GSA) is a piece of hardware that corporations install on-premise so that employees can search enterprise data."
website "http://www.google.com/enterprise/search/gsa.html"

# ShodanHQ results as at 2011-09-16 #
# 4 for EnterpriseController
# 2 for GSE EnterpriseController

# Google results as at 2011-09-16 #
# 19 for inurl:"EnterpriseController" -code

# Matches #
matches [

{ :text=>'If you are an end user looking for a Google search service on your network, please ask your system administrator for the URL of the search service.
' },

# HTTP Server Header
{ :certainty=>75, :search=>"headers[server]", :regexp=>/^GSE$/ },

# Location Header
{ :certainty=>75, :search=>"headers[location]", :regexp=>/^\/EnterpriseController/ },

# About Google Search Appliance
{ :text=>'
About Google Search Appliance

' },

# Welcome to the Google Search Appliance!
{ :text=>'
Welcome to the Google Search Appliance!

' },

# Welcome to the Google Mini!
{ :text=>'
   Welcome to the Google Mini!

' },

# Version Detection # /EnterpriseController?actionType=about
{ :version=>/<\/font>[\s]+

[\s]+System Version:[\s]+([^\s]+)[\s]+<\/font>[\s]+

[\s]+Appliance ID:/ },

]

end


text:
Minnesota State Court Rules
Minnesota Rules of Public Access to Records of the Judicial Branch
Amendments to the Rules of Public Access to Records of the Judicial Branch, Amendment to Minn. R. Civ. P. 47, et al. by Minnesota Supreme Court (May 6, 2005) (Minnesota Supreme Court)
Amendments include:
Amendments to the Rules of Public Access to Records of the Judicial Branch
Amendment to Minn. R. Civ. P. 47.01: Examination of Jurors
Amendment to Rules of the Supreme Court for Registration of Attorneys, Rule 9: Access to Attorney Registration Records
Amendments to General Rules of Practice: Rule 11. Submission of Confidential Information; Rule 313: Confidential Numbers and Tax Returns; Rule 361: Discovery; Rule 370: Establishment of Support Proceedings; Rule 371: Parentage Actions; Rule 372: Motions to Modify, Motions to Set Support, and Other Matters; New Form 11.1 Confidential Information Form (Gen. R. Prac. 11.02); New Form 11.2 Sealed Financial Source Documents (Gen. R. Prac. 11.02); Rule 814: Records.
This document is an attachment to Minnesota Supreme Court Order re: Promulgation of Amendments to the Minnesota Rules of Public Access to Records of the Judicial Branch and Related Rules, May __, 2005, which states in relevant part:
"The attached amendments to the Rules of Public Access to Records of the Judicial Branch, General Rules of Practice for the District Courts, Rules of Civil Procedure, and Rules of the Supreme Court for Registration of Attorneys be, and the same hereby are, prescribed and promulgated to be effective July 1, 2005, except:
as provided in Rule 8, subd. 2(f), of the attached Rules of Public Access to Records of the Judicial Branch, regarding remote access; and
Rules 11, 361.02, 361.05, 370.04, 371.04, and 372.04 of the attached General Rules of Practice for the District Courts regarding restricted identifiers and financial source documents shall apply to pleadings and other documents submitted to, or judgments, orders, decisions, and notices issued, by, the court on or after July 1, 2005.
Limits on Public Access to Administrative Records (Effective 7/1/2005) (June 27, 2005) (Minnesota Judicial Branch)
Limits on Public Access to Case Records (Effective 7/1/05) (June 27, 2005) (Minnesota Judicial Branch)
Limits on Public Access to Vital Statistics Records (Effective 7/1/2005) (June 27, 2005) (Minnesota Judicial Branch)
Minnesota Rules of Public Access to the Records of the Judicial Branch by Minnesota Supreme Court (July 1, 2005) (Minnesota Judicial Branch)
"These rules govern access to the records of all courts and court administrators of the judicial branch of the state of Minnesota. They do not govern access to records of the Tax Court or the Workers' Compensation Court of Appeals, which are part of the executive branch of the state. In addition, these rules do not govern access to records of the various Boards or Commissions of the Supreme Court as they are governed by independent rules promulgated or approved by the Supreme Court."
Minnesota State Court Rules (Minnesota Revisor of Statutes)
These rule sets are published rule by rule and also include an index, making them more usable than those published on the Minnesota Judicial Branch website.
Minnesota State Court Rules Directory and Recent Rules Orders (Minnesota Judicial Branch)
Minnesota Judicial Council


text:
Healthcare Industry News: Chlamydia
Biopharmacetuicals
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Fluoroquinolone antibiotic now available for the treatment of AECB
MONTREAL and WALTHAM, Mass.--(HSMN NewsFeed)--Abbott Canada, the Canadian affiliate of Abbott, has launched Oscient Pharmaceuticals Corporation's (Nasdaq: OSCI ) fluoroquinolone antibiotic, FACTIVE® (gemifloxacin mesylate) tablets in Canada for the five-day treatment of acute bacterial exacerbations of chronic bronchitis (AECB). Oscient granted the commercialization rights for FACTIVE to Abbott Canada in August of last year.
"As the most active member of the fluoroquinolone class of antibiotics in vitro, FACTIVE is an important addition to our anti-infective product portfolio," stated Marcelo A. Vizio, General Manager, Abbott Canada, Abbott International. "We are marketing FACTIVE, with its convenient once-daily dosing and short-course therapy, to physicians across Canada with our primary care sales force."
"With extensive anti-infective experience, Abbott Canada is well-positioned to launch FACTIVE to Canadian healthcare providers," stated Steven M. Rauscher, President and Chief Executive Officer of Oscient Pharmaceuticals. "In Canada, chronic obstructive pulmonary disease patients typically have two to three AECB episodes a year, resulting in 1.5 million physician visits annually."
Abbott Canada plans to pursue additional indications for FACTIVE in the future and has access to the drug's entire clinical trial dossier. In 2004, FACTIVE was approved in Canada for the treatment of AECB caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Staphylococcus aureus. FACTIVE is approved in the U.S. for the seven-day treatment of community-acquired pneumonia of mild to moderate severity (CAP) and the five-day treatment of AECB. Oscient received a modest milestone payment from Abbott Canada related to the launch.
About Abbott Canada
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.
Abbott Canada is headquartered in the borough of Saint-Laurent, Montreal, Quebec, and employs approximately 2,000 people. Its key businesses include nutritionals, pharmaceuticals, diabetes care products, diagnostics, point-of-care products and vascular products.
About Oscient Pharmaceuticals
Oscient Pharmaceuticals Corporation is a commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force. ANTARA® (fenofibrate) capsules is indicated for the adjunct treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE® (gemifloxacin mesylate) tablets is an antibiotic approved in the U.S. for the five-day treatment of acute bacterial exacerbations of chronic bronchitis and the seven-day treatment of community-acquired pneumonia of mild to moderate severity. Oscient also has a novel, late-stage antibiotic candidate, Ramoplanin, under investigation for the treatment of Clostridium difficile-associated disease (CDAD).
Notice to U.S. Healthcare Providers: For important information regarding the safety and use of ANTARA, please see the full prescribing information available at www.antararx.com.
Important Safety Information about FACTIVE for Canadian Prescribers (1)
FACTIVE is contraindicated in patients with a history of hypersensitivity to gemifloxacin, fluoroquinolone antibiotics, or any of the product components. FACTIVE may prolong the QT interval in some patients and should be avoided in patients with a history of prolongation of the QTc interval, patients with uncorrected electrolyte disorders (hypokalemia or hypomagnesemia), and patients receiving Class IA (e.g., quinidine, procainamide) or Class III (e.g., amiodarone, sotalol) antiarrhythmic agents.
FACTIVE should be discontinued immediately at the appearance of any sign of an immediate hypersensitivity skin rash or any other manifestation of a hypersensitivity reaction; the need for continued fluoroquinolone therapy should be evaluated. FACTIVE should be used with caution in patients with CNS diseases such as epilepsy, or in patients predisposed to convulsions. FACTIVE should be discontinued if the patient experiences pain, inflammation or rupture of a tendon.
(1) FACTIVE Product Monograph. Abbott Laboratories, Limited. August 22, 2006.
For additional information regarding the safety and use of FACTIVE in Canada, please see the full product monograph available at www.abbott.ca.
Important Safety Information about FACTIVE for U.S. Prescribers
FACTIVE is indicated in the U.S. for the five-day treatment of AECB caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae or Moraxella catarrhalis and the seven-day treatment of CAP caused by Streptococcus pneumoniae (including multi-drug resistant strains), Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, Chlamydia pneumoniae or Klebsiella pneumoniae.
The most common (more than 2% incidence) drug-related side effects reported in FACTIVE clinical trials were diarrhea (3.6%), rash (2.8%) and nausea (2.7%). In clinical trials, drug-related rash was reported in 2.8% of patients receiving gemifloxacin and was more commonly observed in patients less than 40 years of age, especially females. The incidence of rash increases with treatment longer than the maximum-labeled duration of 7 days. In clinical trials, the discontinuation rate due to drug-related adverse events was similar for FACTIVE tablets and comparators (2.2% versus 2.1%, respectively).
Gemifloxacin is contraindicated in patients with a history of hypersensitivity to gemifloxacin, fluoroquinolone antibiotic agents, or any of the product components. Patients receiving marketed fluoroquinolones have reported serious and occasionally fatal hypersensitivity and/or anaphylactic reactions, peripheral neuropathy, antibiotic-associated colitis and tendon ruptures. Gemifloxacin should be discontinued immediately at the first sign of any of these events.
Fluoroquinolones may prolong the QT interval in some patients. Gemifloxacin should be avoided in patients with a history of prolongation of the QTc interval, patients with uncorrected electrolyte disorders (hypokalemia or hypomagnesemia), and patients receiving Class IA or Class III antiarrhythmic agents. In clinical studies with gemifloxacin, CNS effects have been reported infrequently. As with other fluoroquinolones, gemifloxacin should be used with caution in patients with known or suspected CNS diseases. If CNS reactions occur, gemifloxacin should be discontinued and appropriate measures instituted.
No significant drug-drug interactions were seen with theophylline, digoxin, oral contraceptives, cimetidine, omeprazole, and warfarin, although patients receiving a fluoroquinolone concomitantly with warfarin should be monitored closely. Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. The safety and effectiveness of gemifloxacin in children, adolescents (less than 18 years of age), pregnant women, and lactating women have not been established. For complete safety and efficacy information, please see the full prescribing information available at www.factive.com.
Forward-Looking Statement for Oscient Pharmaceuticals
This news release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements with regard to Abbott Canada's plans to pursue additional indications for FACTIVE in the future. Forward-looking statements represent our management's judgment regarding future events. Forward-looking statements typically are identified by use of terms such as "may," "will," "should," "plan," "expect," "intend," "anticipate," "estimate," and similar words, although some forward-looking statements are expressed differently. We do not plan to update these forward-looking statements. You should be aware that our actual results could differ materially from those contained in the forward-looking statements due to a number of risks affecting our business. These risks include, but are not limited to (a) our ability to successfully commercialize and market ANTARA or FACTIVE due to: the limitations on our resources and experience in the commercialization of products; lack of acceptance by physicians, patients and third party payors; unanticipated safety, product liability, efficacy, or other regulatory issues; delays in recruiting and training sales personnel; problems relating to manufacturing or supply; delays in the supply of products by the third party manufacturers and suppliers on which we rely; inadequate distribution of the products by wholesalers, pharmacies, hospitals and other customers; and competition from other products; (b) our ability to integrate ANTARA into our business; (c) whether we will be able to expand the indications for which FACTIVE is approved;(d) the delay in or inability to obtain additional regulatory approvals of our products and product candidates due to negative, inconclusive or insufficient results in ongoing or future clinical trials, the FDA requiring additional information or data, delays in the progress of ongoing clinical trials, safety concerns arising with respect to our products or product candidates and disputes with the third parties from whom we license our products or product candidate; (e) delays by the FDA; (f) the Company's inability to raise additional capital on favorable terms or at all and (g) claims against us by third parties, including claims relating to our intellectual property position. Additional factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements are described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter ending September 30, 2006 and in other filings that we may make with the Securities and Exchange Commission from time to time.
Source: Oscient Pharmaceuticals
Search: Oscient Pharmaceuticals
Search: Abbott Canada
Search: Abbott
Search: gemifloxacin
Search: FACTIVE


The Big Idea: Children are better able to work through emotions when they can name them and talk about them.
Print copies of the feelings cards for each participant. Before the workshop, complete one set of the feelings cards to use as an example.
As you begin, hand out copies of the feelings cards and let participants know that this workshop will help children develop a rich vocabulary of feeling words. Explain why this is important: children will be better able to cope with emotions when they can name and describe them.
"angry means you feel mad." Invite participants to write a feeling word they'd like to teach kids on one of their blank cards. Let them know that kids can fill in the other blank cards with more feeling words at home.
Show participants the completed poster page and how the cards fit into the slot. Encourage them to hang this at home somewhere kids can see and reach. Encourage them to use this as a way to help kids check in with their feelings any time. They could even set a daily check-in time, such as bedtime.
Lay out three emotion cards. Choose someone to act out one of the emotions. Challenge others to guess the emotion they are acting out.
Turn on some music. Hold up different feelings and have participants move in a way that expresses those feelings.
Have participants draw their own picture or write their own memory to go along with each feeling.


text:
Bipartisan Support for Federal Diesel Emissions Reduction Bill
Established in 2005 to reduce toxic diesel emissions, the Diesel Emissions Reductions Act expired in 2016. A bipartisan effort appears to be in place to see it reauthorized this year.
March 23, 2019, 11am PDT | Irvin Dawid
welcomia
"Sen. Tom Carper led his colleagues in introducing bipartisan legislation [S.747] that would reauthorize the Diesel Emissions Reduction Act through fiscal 2024," reports Eugene Mulero for Transport Topics.
The program, administered by the U.S. Environmental Protection Agency, relies on federal grants and rebates. The funding is used to help finance the voluntary replacement or installation of retrofits on existing heavy-duty diesel vehicles and engines.
The program is so successful, every dollar invested in DERA generates a 13-fold return in health and economic benefits," said Carper (D-Del.), ranking member on the Environment and Public Works Committee.
"U.S. Senator John Barrasso (R-Wyo.), chairman of the Senate Committee on Environment and Public Works (EPW), highlighted the importance of the Diesel Emissions Reduction Act (DERA) to communities in Wyoming," according to his March 13 press release. [Bill number not available as of March 18].
Barrasso noted several school districts in Wyoming have used funds from the DERA program to replace aging school buses, both to improve efficiency and reduce emissions.
"This funding has been key to incentivizing and expanding port environmental programs to improve air quality impacted by port operations," American Association of Port Authorities stated during an EPW hearing March 13. Other DERA proponents include American Trucking Associations for reasons acknowledged by Sen. James Inhofe (R-Okla.) a day earlier:
"The program has been used to voluntarily upgrade more than 73,000 diesel-powered vehicles, all while creating lucrative manufacturing jobs. I am proud to have supported the program since it was first created more than a decade ago and I am proud to once again introduce bipartisan legislation to reauthorize such an effective program with Sens. Carper, Barrasso and Whitehouse."
"On March 14, House lawmakers followed their EPW Senate counterparts to unveil a version of the DERA reauthorization," adds Mulero. "The House bill also would enable upgrades to diesel engines."
Bipartisan support does that mean the bill will succeed. Mulero noted that notwithstanding the chairman's apparent support for the program, at the March 13 hearing he "would not specify when the panel would take up the bill during the 116th Congress."
However, a DERA reauthorization bill did pass the Senate last year, but the House bill was never heard. With Democrats in control of that branch of Congress, perhaps it will fare better this year, although the bill is yet to be numbered as of March 18 and doesn't show on the House Committee on Energy and Commerce website.
Successful bipartisan legislation passed by the Senate Committee on Environment and Public Works:
The committee's webpage notes these three bills that became laws:
President Trump Signs Bipartisan Wildlife Conservation Legislation into Law, March 12, 2019. The WILD Act was included in S. 47, the Natural Resources Management Act, posted here.
President Trump Signs Bipartisan Nuclear Energy Legislation into Law, January 14, 2019 [S. 512]
President Trump Signs America's Water Infrastructure Act into Law, October 23, 2018 [S. 3021]
Senators Introduce Diesel Emissions Bill
Published on Friday, March 15, 2019 in Transport Topics
America's Water Infrastructure Act
Bipartisan
Bipartisan Legislation
Committee on Energy and Commerce
Natural Resources Management Act
Nuclear Energy Innovation and Modernization Act
Senate Environment and Public Works Committee
American Trucking Associations
Sen. John Barrasso
Sen. Tom Carper
Eugene Mulero


10 New Years Champagne Recipes to Kick Off the New Year!
Celebrating the new year wouldn't be the same without popping a bottle of bubbly. Instead of sticking to the traditional glass of champagne, try these simple, yet statement worthy recipes that will give you a better new years experience!
This Godiva Chocolate Champagne cocktail recipe is great for those who have a sweet tooth!
This Fortune Cookie Champagne Cocktail recipe is a fun way to bring a positive outlook to the New Year.
The Champagne Margarita Cocktail adds an extra kick for those who really like to loosen up and have a good time. Tequila is always a good idea!
Pour Tequila, Triple Sec, and freshly squeezed lime juice into a shaker with ice and mix well.
Add champagne to shaker and slowly tilt the shaker side to side 2 times.
Rock Candy Champagne is a fun drink with easy to put together ingredients. Not only is the recipe super easy, it's also unique and tasteful!
Save yourself the trouble of having desert — just include in your drink. Our Champagne Dessert recipe is great for an after dinner delight!
This Cotton Candy Cocktail is another easy and unique New Years recipe that is gauranteed sweet and delicious.
Champagne Jello Shots never disappoint! A tasty and sneaky way to get a nice buzz, fast! Here's how to make Champagne Jello Shots on New Years, one of our favorites.
Drink yourself into the clouds with this Dreamy Bellini Cocktail Recipe. It's simple, and brings the perfect amount of sweetness. Your taste buds will keep asking for more!
The Blue Dream Cocktail really is a dream!! Both good looking and yummy, you can't go wrong with this cocktail recipe.
Always a classic, the Cranberry Pear Champagne Cocktail adds a touch of class to traditional champagne in a glass.
Additional photos and New Years Champagne recipe concept insight courtesy Pinterest, The Brunette One, Nico and Me, Lauren Conrad, Receitando, SuzieSweetTooth, TheFrugalNavyWife, The Kitchen is my Playground, Thread Sence, and Savory Sweet Life.


text:
757-871-7394 julia@athletescoalition.org
GRAMMIN'
Meet the crew that helps guide The Athletes' Coalition
Silke Koester
Co-founder, Rocky Mountain Runners
Silke Koester lives in Boulder, CO where she co-founded the local community-based running club, the Rocky Mountain Runners. Silke runs for the La Sportiva Mountain Running Team, writes for Trail Sisters and is a Sisu Girls ambassador. She has been running ultras for over a decade and completed some of the most famous races in the world including the Western States Endurance Run and the Ultra Trail du Mont Blanc.
When not on the trails, Silke works full-time in the educational non-profit world with K-12 public schools around the US that are drastically improving school for all kids. Not one to sit still, she enjoys beekeeping and embarking on overly ambitious DIY home remodeling, landscaping & carpentry projects. Her biggest project yet is her daughter, born in September 2017.
Meredith Miller
Former professional cyclist, road + cyclocross, Rapha Boulder RCC Coordinator + Marketing
Meredith began racing bikes as an amateur in 1998 and became a full-time racer when she moved to Copenhagen in 2003. After three years in Europe with the Danish program Team SATS, Meredith moved back to a US squad, Team Lipton, with the likes of three-time Olympic gold medalist Kristin Armstrong. In 2008 Meredith picked up cyclocross and for six years alternated between an extensive road schedule and an intense cyclocross calendar. Beginning to feel the effects of two back to back seasons, Meredith put road racing on the back burner to focus exclusively on cyclocross. In her last two years of racing cyclocross, Meredith co-owned and managed her own racing program, Team Noosa. Eighteen years after entering her first bike race, Meredith retired from professional racing after the World Cyclocross Championships in Zolder, Belgium in 2016.
Meredith works for Rapha Boulder as the RCC Coordinator and marketer. She manages events and rides for Rapha and still spends significant time riding in the hills and dirt around Boulder with people in the cycling community. Unwilling to give up competition, it's not unlikely to find the Boulder-based cyclist on the start line of cyclocross or gravel races around the country. She and her husband enjoy riding and traveling together and have one dog, Haka.
Mike Randall
Entrepreneur & Mountain Enthusiast
Mike Randall has spent 30+ years as an entrepreneur, private investor, consultant, and strategic advisor, helping lead multiple companies from concept to exit. Current areas of focus include commercial real estate, alternative lending, and e-commerce and marketplace start-ups.
Based in Boulder, Colorado, Mike is an avid mountain-ultra-trail runner, with 100-mile race finishes in iconic races in Texas, Colorado, Utah, Wyoming, and California. Much of his time is spent traveling the world with family and friends in search of new ways to consume and burn calories.
Forrest Merithew
Lawyer, Outdoor Recreation Industry
Forrest is an active outdoors person, who enjoys probably too many activities, own being his day job as an attorney heading his own legal practice, Merithew Law, which focuses on the outdoor recreation industry. He has grown the general counsel and consulting practice with two cross-country locations to better provide comprehensive services for any commercial or creative endeavor, including, but not limited to, entities, contracts, branding, risk management, intellectual property, insurance coverage, and product development and liability. He enjoys being a resource for businesses, individuals and entrepreneurs who have a passion for what they do.
Forrest is originally from Asheville, North Carolina, but has lived on both coasts and currently resides in Fort Collins, CO. In addition to his day-to-day work, he enjoys being involved in greater causes for the outdoors and the industry it fosters. He will try anything once and regularly mountain bikes, runs, hikes, SUPs, climbs, and snowboards. He and his wife met playing beach volleyball in San Diego during their graduate academic studies and are currently enjoying the adventure of their first child.
© 2018 The Athletes' Coalition. fluxx.co ⚡


Alaskans now can look at what is believed to be every substantial energy source in the state.
The Alaska Energy Authority and the Department of Natural Resources today released a 144-page study by the state's Division of Geological and Geophysical Surveys that shows information currently available from across the state on sites containing usable quantities of fossil fuels and geothermal energy . It joins two other volumes published by the Energy Authority that show likely sources of renewable energy that could be used by communities.
DNR Commissioner Dan Sullivan said the publications are a tool for communities that now face very high energy costs.
Typically as we've been looking in the state, we look to the North Slope in terms of Prudhoe Bay. We look to Cook Inlet. And those are very well-known hydrocarbon basins. But the state has resources in terms of fossil fuels in almost every different part of the state. And we think what is very important is to lay out where and what those resources are.
Sullivan says the information is part of what communities, native corporations and regional planners will need for local development – calling it a book of possibilities, not answers.
State Geologist Bob Swenson said he was surprised by data showing considerable geothermal resources in the Aleutians – and a very large coal deposit near Kotzebue. He said the best use of the report is to remove guesswork from plans.
This is not meant to replace anything. If the best, most economic resource is renewable by all means that is definitely what the community should go after and do. What's really important to make that analysis is to have the realistic information for you to make the analysis.
Today's report will be combined online with the previous Energy Authority data here. It is now available in its entirety at this page.


GunBroker.com is the largest online marketplace dedicated to firearms, hunting, shooting and related products.
Our FFL Dealer Locator makes it easy for buyers to find an FFL holder to manage the transfer of the firearms purchase.
Our Forums allow you to talk to other users about firearms issues or find out how much an item is worth.
We have a Free Package of Services to help licensed dealers take advantage of the Internet.
We offer tutorials in our Basic Training section to get you up to speed.
We offer discounted FedEx shipping to GunBroker.com members. Get super savings AND ship & track all of your packages from one convenient website.
Third party sellers list items on GunBroker.com. The Seller can choose to list the item in an Auction-style format, accepting only bids for the item, and/or list using the BuyNow! or Fixed Price option, allowing buyers to purchase the item right away at a set price.
Once the item is won or purchased, the Buyer pays the Seller directly.
If the item requires an FFL, the Buyer finds a transfer dealer (FFL) to handle the transfer, sends the FFL information to the Seller, and the Seller ships the item to the Buyer's FFL. GunBroker.com maintains a list of FFL Holders who are willing to manage the legal transfer of firearms to unlicensed persons.
The FFL peforms NICS and then transfers the firearms to the Buyer. FFLs typically charge the Buyer a transfer fee.
If the item does not require an FFL, the item is shipped directly to the Buyer.
Launched in 1999, GunBroker.com is an informative, secure and safe way to buy and sell firearms, ammunition, air guns, archery equipment, knives and swords, firearms accessories and hunting/shooting gear online. GunBroker.com promotes responsible ownership of guns and firearms.


Obviously, it has been some time since I last wrote. I usually save my rants for private conversation, but for whatever reason (which will be explored), I feel the need to explain my thinking about the reaction to the iPad.
Speculation about Apple's entry to the tablet market has been persistent since OS X's introduction, particularly given the context of Apple's technical achievement with the Newton. Like the iPad, the Newton was intended to re-invent personal computing. Another possible parallel is that the end product was pronounced to be complementary to the Mac rather than its replacement.
In the lead-up to the announcement, rumors set expectations that the product to be released would be a tablet Mac. The introduction of the MacBook Air gave some credibility to the idea that a nice tablet Mac was technically feasible – subtracting the keyboard and flipping the screen would give a thin, light, and adequately-powerful tablet.
Still, I didn't understand how such a Mac machine would make sense on the software side. OS X software is built with a certain interface paradigm in mind: the mouse and keyboard. The size of the controls and the flow of interaction in general are based on this set of input tools. On the other hand, the iPhone OS was designed from the beginning to be "OS X touch" – the internals are similar, but the UIs of the operating system and the applications for it are radically different to accommodate multitouch input – so much so that it is seemingly the only input method considered.
Additionally, if stylus-based input was deemed insufficient for the iPhone, what sense would it make given a display many times the size of that of the iPhone? The larger display does not eliminate the problems with an on-screen keyboard, but certainly if people have adapted to typing on an iPhone display, doing so on the iPad display is going to be considered "good enough" to accept the trade-offs of implementing something like handwriting recognition.
On the day it was released, there were few positive reactions. My initial reaction was disappointment, more or less – I wanted a Magical Mac Tablet as much as everyone else. But then I started to remember.
I remembered the day in 2001 when Apple was known to be releasing the iPod and the famous cmdrtaco reaction. The limitations seemed staggering: it used FireWire, which no sane PC manufacturer (save Sony) included on their consumer PCs at the time. And iTunes wouldn't even be available for Windows for another 2 years. It wasn't the wireless-data-beaming, PDA-mashing device everyone hoped for. The MP3 player had been on the market for years and the AA-eating Nomad had been providing gigabytes of storage for some time. Things seemed bleak. Yet somehow, it eventually caught on. The Windows issue was resolved, USB was adopted, and the Dock Connector promoted a self-perpetuating accessory bonanza. It survived Microsoft's (epic or half-assed, whatever your view) effort with the Zune. As of this quarter, Apple has sold 250 million iPods. Somehow, it worked out.
Logically, then, I remembered 2007 when the iPhone was launched. Several prominent figures believed there was "no chance" that Apple would gain significant market share in smartphones. This time, Apple raised a high-enough profile that everyone was sure to prophet its demise over one or many of its "missing features": multitasking, copy and paste, MMS, native SDK, Flash support, A2DP, support for other carriers, Outlook support, user-replaceable battery, physical keyboard, among them. Yet thanks to the magic of software, several of these shortcomings have been addressed. Some remain unaddressed. In either case, people bought the damn thing, shortcomings or not. Several of them liked it. And several of those are exactly the same people predicting its failure.
I don't know if I agree that present demand is what has driven the creation of the iPad, but certainly, I agree that there is a desire for a computer that enables The Real Work instead continuing our notion that pointing and clicking equates to work getting done.
So that, then, amounts to my poorly-reasoned argument of why I think the iPad will sell well. It has nothing to do with Apple having some sort of superior exclusive technology or killer app today – things like that evaporate quickly in this industry. It's that they have laid the groundwork for a new product space in the same way they did with the iPod and iPhone. The iPod changed what we expect when we enjoy music and video. The iPhone changed what we expect from a mobile phone. I think that in the same way, the iPad will change what we expect from software. And the best part about software is that the new killer app is just a click away.


Yihong Ding, contributing author of Semantic Focus, has released a Chinese language version of his Thinking Space blog. For now he'll be translating his existing articles from English to Chinese, but as time goes on he says he may post exclusive articles for his Chinese-speaking audience. If you prefer reading about the Semantic Web in Chinese then this is the blog for you!


I've received several emails recently inquiring about the best pens for tangling on fabric, especially in color. I haven't explored this myself yet but many fellow Zentangle Zealots have experience using fabric gel pens and I thought I'd share some of the ones that have been recommended. These pens are also shown in the slideshow at the bottom.
In the video below, CZT Suzanne McNeill describes various pens she tested on fabric scraps that were also laundered before she began her project.
On a purchased apron of lightweight canvas Suzanne tangles using a Pentel Gel Roller for Fabric. This fabric has quite a lot of tooth and she recommends using a Pentel Gel Pen for similar fabrics.
On the Quilt block project on a softer muslin fabric, Suzanne recommends a smoother pen point like the regular Sakura Micron permanent ink pens we use for our Zentangle tiles, or a Tee Juice Marker by Jacquard.
As a special project at the CZT #7 seminar many chose to tangle a T-shirt. One of the tips from that extra evening class was to be sure to use a piece of heavy card stock between the layers of the shirt so you not only have a good support to work on, but it prevents bleedthrough to the other side of the garment. For this project, the Sakura IDentipen was used for the black ink and a Tsukineko Fabrico Dual Marker (#181 Cool Gray) for shading.
Another tip for tangling on stretchy knit fabric like tees is to iron a piece of freezer paper on the underside of the layer you're tangling. This stabilizes the fabric and also prevents bleedthrough.
Of all the fabric projects I've seen, this is the one I'm most likely to do. Maria Thomas, co-founder of Zentangle, enthusiastically endorses recycling your own gently-used white sheets, or purchasing economical white or off-white sheets from stores such as Target. Rip them into dinner napkin-size squares, fray the edges a bit, then tangle your own individualized napkins for daily use. You can get quite a few from a single sheet and as Maria says, this green project will save a TON of paper napkins. Not to mention they are so much nicer to use than a paper napkin. Black and white, or color, it's up to you.
Here's Suzanne with her recommendations. The two books she displays are Zentangle Fabric Arts, and the Zen Quilting Workbook – see the BOOK REVIEWS tab at the top of this page for more info about them.
If you can recommend additional fabric pens or would like to share your experience with the ones mentioned, please feel free to add a comment. Enjoy!
Here in South Africa, where it is not easy to get these brands, I've found an Artline marker good for fabric, especially the 725. It washes well, without any bleeding or fading in the wash. Costs about R17.
If you want to tangle on fabric and then embroider the pattern, use a pilot frixion pen. After embroidering, iron the fabric and the ink will disappear. Be sure to use a tight embroidery hoop to keep the embroidery flat.
pentel no longer makes the Fabric Gel Roller. Does anyone know of another comparable pen?


I am looking at your site on the subject of your aplication DBFView. We currently work with Excel 2007 on XP operating systems. We save excel files as DBF IV format so that we can import them into other product that we use. Will this program work with Excel 007(. Xlsx)?
SHP to XLS at Convert Software Informer Download Convert Shp To Xls at Convert Informer: Convert XLS, XLS Converter, Convert XLS to PDF For Excel.
Xls To Shp : DBF Viewer, DBF Editor, DBF Convertor : All-in-1 Xls To Shp DBFView View, edit and print your dbf files!
xls 15 channel frs - Online Shopping at BizRate. Compare Buy xls 15 channel frs at BizRate, the best price comparison search engine on the web. Shop, compare and save when you buy online.


WASHINGTON: Democrats rode a wave of dissatisfaction with President Donald Trump to win control of the US House of Representatives on Tuesday, Fox News and NBC News projected, giving Democrats the opportunity to block Trump's agenda and open his administration to intense scrutiny.
At last count, Democrats had gained a net 14 of the 23 Republican-held seats needed to capture a majority.
Most Democratic candidates in tight races stayed away from harsh criticism of Trump during the campaign's final stretch, focusing instead on bread-and-butter issues like keeping down health care costs, maintaining insurance protections for people with pre-existing medical conditions and safeguarding the Social Security retirement and Medicare health care programs for senior citizens.
Senators Bernie Sanders of Vermont, a 2016 Democratic presidential contender, and Tim Kaine of Virginia, Hillary Clinton's vice-presidential nominee in 2016, easily won re-election, news networks projected. Democratic Senator Sherrod Brown was projected to hold his seat in Ohio.


text:
DNA technology identifies human remains found in B.C. decades ago
Adam Chan CTV News Vancouver Island Associate Digital Producer
Published Thursday, January 28, 2021 11:38AM PST Last Updated Thursday, January 28, 2021 2:50PM PST
The reconstructed faces of unidentified deceased people are shown using clay on top of 3D-printed skulls.
VICTORIA -- A decades-old missing person's case that spanned British Columbia has recently been solved through advancements in DNA profiling.
BC RCMP and the BC Coroners Service say that a missing person's case that dates back to 1967 was resolved nearly 54 years later. The case began in Kamloops when a family reported the disappearance of a man on May 27, 1967. He was last seen in Coquitlam and was 41 years old at the time.
Years later, in 1972, unidentified human remains were discovered on a beach on Saturna Island, one of B.C.'s southern Gulf Islands. While an autopsy was performed at the time, the remains were never identified and were buried on Salt Spring Island.
Nearly 40 years later, the remains were exhumed in September 2020 and DNA was recovered to compare with samples from suspected family members.
"After a lengthy scientific process performed at a British Columbia laboratory, complicated by the degradation of the remains, a DNA profile of the deceased was finally obtained," said BC RCMP spokesperson Cpl. Jesse O'Donaghey in a release Thursday.
"As a result of a comparison, conducted by our partners with the BC Coroners Service Special Investigations Unit, an identity for the deceased was established thanks to the detailed work of investigators who had obtained a sample of familial DNA for comparison," he said.
O'Donaghey told CTV News that investigators do not believe there was any criminality involved in the man's death, and the missing person case is now considered closed.
RCMP on the Lower Mainland had collected DNA from the missing man's daughter back in 2014 when a review of the historical missing person file was conducted.
In 2019, the BC Coroners Service launched an interactive map tool to help chart nearly 200 cases of unidentified human remains, which dated back to the 1950s.
At the same time, BC RCMP had partnered with the New York Academy of Fine Art to develop facial reconstruction technology based on unidentified human remains and 3D-printed skulls.
"Through scientific advancements in identification processes, we are now able to solve such historic cases," said Eric Petit, Director of the BC Coroners Service Special Investigations Unit.
"In this instance, we were able to piece together the puzzle that had been challenging us on Salt Spring Island since in 1972," he said. "The partnership we have garnered over the years with both the police and the BCIT lab makes success possible. Through collaboration, we are able to work as one team with the ultimate goal to provide families the closure they had been seeking for more than fifty years."
The family of the missing man have asked to remain anonymous but thank investigators for identifying their relative.
"Thank you from the family to all RCMP members, the coroners, and the team involved in dedicating their time and efforts to bring this missing persons case to a close."
Can you help RCMP solve the mystery of these unidentified human remains?
B.C. coroners release map of nearly 200 unsolved cases
New era in B.C. overdose crisis?
Dozens of animals die in fire
Vancouver Island Top Stories
More From CTV News Vancouver Island
Number of people leaving B.C. for Alberta reaches 20-year high
Vancouver Island city councillor charged with assault
'I've only got one set of hands': Last remaining ER doctor in B.C. town wants to hire assistant with own money
Victoria man plans to take 'a very special lady for dinner' after $100K lottery win
Breaking down Poilievre's first bout with Trudeau
Air Date: September 22, 2022
New Langford school opens to hundreds of students
Owl breaks into two homes in Oak Bay
3 university football players killed in shooting
Investigators continue to probe Parksville fire
Report reveals new details in Lindsay Buziak murder case
Accused Brentwood Bay murderer faces new charges
Behind closed doors, brothels thrive as licensed escort agencies in Victoria
Victoria mother admits to killing toddler by drugging, smothering her in murder trial


Heading home after a stay in the hospital is often a relief, but it can also be an uncertain, overwhelming time. You may have some lingering medical needs that make it difficult to do all the things you're accustomed to, and that may also cause concern about whether you will be able to take care of routine household responsibilities.
It's important to have a good plan and support network in place before you head home so that you'll be able to focus all your energy on recovering.
The process of transitioning back home after a hospital stay can create challenges for you and your family, but it can also be a wonderful relief as you look forward to moving back into the comfort of home. Here are some tips to help you prepare both mentally and physically.
Prepare a detailed transition plan. A transition plan can break an intimidating process down into manageable parts. Talk to your doctor and family members about post-hospital care, transportation needs, and rehabilitation expectations. Your plan should include any follow-up appointments you'll need, a medication management strategy, and the potential need for additional care and assistance once you arrive home.
Acknowledge that parts of your life might look different. For example, if you are used to walking every morning, handling all your own housework, and not needing help from anyone, it's important to mentally prepare for a new routine. Accepting help from family, friends, and caregivers is one of the best ways to move back toward a comfortable, productive lifestyle at home.
Don't neglect the healing process. You most likely still have some physical limitations, and you may need additional therapy to recover from the injury or illness you experienced. Be sure to participate in this rehabilitation process and give yourself time to recover. You don't need to jump right back into every activity you were doing before. Give yourself time to heal.
Consider changes to your home environment. If you will be using a wheelchair or walker, you may need to install ramps, rearrange furniture, or make other structural changes to your home so you can move around more easily. Even if you don't need assistance with mobility, it's a good idea to consider safety measures such as non-slip treads on steps and in the bathtub, grab bars in the shower and bathroom, and nightlights in case you need to get up during the night. You may also want to move items you use regularly off of high shelves to reduce the need for step ladders or other fall risks.
Ask for help. There is no shame in admitting you need additional help. You have been through a traumatic experience, and you will need time to recover following your hospital stay. Talk with your doctor about what you should expect in terms of recovery time and whether you will regain full mobility, and then reach out to family members who can help you make decisions about care. If you don't have family who can come and help out, a professional caregiver can give you the help you need so that you can maintain your independence at home.
Household responsibilities - Your caregiver can assist with meal preparation, light housekeeping, and even laundry so that you can get the rest you need without feeling overwhelmed by housework.
Transportation to appointments - If you don't have family nearby to help with transportation, your caregiver can drive you to any follow-up appointments you have with your doctor.
Grocery shopping - Grocery shopping may seem like an overwhelming task if you are struggling to get around, especially if you have new dietary requirements following an illness. Your caregivers can help you plan meals and shop for groceries that meet your nutrition needs so you always have plenty of options on hand.
Personal care - If you have a broken bone or limited mobility, a caregiver can help you with personal care needs such as bathing, dressing, and getting to and from the bathroom.
What Are the Benefits of Home Care Services with Cherished Companions?
At Cherished Companions, our goal is to help you enjoy your independence while creating a safe, comfortable environment at home. We customize care plans based on your individual circumstances, and we offer as much or as little help as you need.
Customized Care Options - No matter how much or how little assistance you need, we will create a care plan just for you. From light housekeeping to mobility assistance and fall prevention, our customized options are designed around your unique situation.
Flexible Hours/Shifts - Not everyone needs a full-time caregiver. That's why we offer flexible hours and shifts, from two hours at a time up to 24-hour/live-in care.
Regular Communication - We will keep you and your family informed about your progress each step of the way. You can even choose your preferred communication method, whether that's phone, text, or email.
Companionship - Physical limitations often affect your ability to get out and socialize like you used to. Our caregivers enjoy spending time with each of our clients, and we believe that this companionship is vital to the healing process.
If you would like to know more about the caregiving options available to you, please give us a call. We would love to talk with you about how a caregiver can support you as you transition back home after your hospital stay.